Skip to content

Author

S. Day

We have 3 of 23 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 4980: Interplay Between Body Mass Index and Patient-Reported Health Status in Early-Stage Hypertrophic Cardiomyopathy

Background: Symptoms and functional impairments have historically represented the primary targets of hypertrophic cardiomyopathy (HCM) management. Obesity has been shown to be associated with worse symptoms and clinical outcomes in HCM, but the extent to which obesity influences patient-reported health status across...

J. Ostrominski, B. Claggett, A. Axelsson Raja et al. · 0 citations
Sep 2026

Atrial Fibrillation in Genotyped Dilated Cardiomyopathy: Epidemiology, Risk Factors, and Outcomes: Insights From the SHaRe Registry.

BACKGROUND Atrial fibrillation (AF) is the most common arrhythmia in dilated cardiomyopathy (DCM) and is associated with adverse outcomes. However, the genetic determinants of AF risk and its prognostic significance across genotyped DCM subtypes remain unknown. METHODS In this observational cohort study, we analyzed...

I. Balakrishnan, A. Heymans, B. Claggett et al. · 0 citations
Sep 2026

The molecular landscape of hypertrophic cardiomyopathy across disease stages and genotypes.

Unsupervised and supervised machine learning approaches distinguished HCM from dilated cardiomyopathy and accurately predicted genotype status in early-stage HCM from cell type-resolved transcriptional profiles, revealing widespread genotype-driven remodeling.

E. Adami, Yuri Kim, Sean L. Zheng et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.